HB3454
IL · 104th · HouseEPINEPHRINE DELIVERY DEVICE
Signed into lawPublic Act . . . . . . . . . 104-0762 · August 7, 2026
Log in to follow this bill and see its votes in your feed.
Introduced February 7, 2025 · Source
Votes (3)
- HousePassed
Concurrence, Amendment 2
May 31, 2026
Yea 116 · Nay 0 · Other 2 · 118 individual positions on record
- SenatePassed
Third Reading
May 28, 2026
Yea 59 · Nay 0 · 59 individual positions on record
- HousePassed
Third Reading
February 25, 2026
Yea 105 · Nay 0 · Other 13 · 118 individual positions on record
Committee votes (3)
Votes in committee, not by the full chamber.
- House Prescription Drug Affordability & AccessibilityPassed
Motion to Concur Recommends Be Adopted: Senate Floor Amendment No. 2
Prescription Drug Affordability, Amendment 2
May 29, 2026
Yea 13 · Nay 0 · 13 individual positions on record
- Senate InsurancePassed
Do Pass
Insurance
May 5, 2026
Yea 9 · Nay 0 · Other 5 · 14 individual positions on record
- House Prescription Drug Affordability & AccessibilityPassed
Do Pass / Short Debate
Prescription Drug Affordability
March 19, 2025
Yea 13 · Nay 0 · Other 1 · 14 individual positions on record
Sponsors (11)
Primary (2)
- Joyce Mason (Democratic)
- Suzy Glowiak Hilton (Democratic)
Cosponsors (9)
- Camille Lilly (Democratic)
- Dee Avelar (Democratic)
- Harry Benton (Democratic)
- Janet Yang Rohr (Democratic)
- Omar Williams (Democratic)
- Marti Deuter (Democratic)
- Mary Edly-Allen (Democratic)
- Michelle Mussman (Democratic)
- Natalie Manley (Democratic)
History (56)
Public Act . . . . . . . . . 104-0762
August 7, 2026 · House
Effective Date January 1, 2027
August 7, 2026 · House
Governor Approved
August 7, 2026 · House
Sent to the Governor
June 26, 2026 · House
Passed Both Houses
May 31, 2026 · House
House Concurs
May 31, 2026 · House
Senate Floor Amendment No. 2 House Concurs 116-000-000
May 31, 2026 · House
Senate Floor Amendment No. 2 Motion to Concur Recommends Be Adopted Prescription Drug Affordability & Accessibility Committee; 013-000-000
May 29, 2026 · House
Senate Floor Amendment No. 2 Motion to Concur Rules Referred to Prescription Drug Affordability & Accessibility Committee
May 29, 2026 · House
Added Chief Co-Sponsor Rep. Natalie A. Manley
May 29, 2026 · House
Senate Floor Amendment No. 2 Motion to Concur Referred to Rules Committee
May 29, 2026 · House
Senate Floor Amendment No. 2 Motion Filed Concur Rep. Joyce Mason
May 29, 2026 · House
Placed on Calendar Order of Concurrence Senate Amendment(s) 2
May 28, 2026 · House
Arrived in House
May 28, 2026 · House
Added as Alternate Co-Sponsor Sen. Mary Edly-Allen
May 28, 2026 · Senate
Senate Committee Amendment No. 1 Tabled Pursuant to Rule 5-4(a)
May 28, 2026 · Senate
Third Reading - Passed; 059-000-000
May 28, 2026 · Senate
Placed on Calendar Order of 3rd Reading
May 28, 2026 · Senate
Senate Floor Amendment No. 2 Adopted; Glowiak-Hilton
May 28, 2026 · Senate
Recalled to Second Reading
May 28, 2026 · Senate
Rule 2-10 Third Reading Deadline Established As May 31, 2026
May 22, 2026 · Senate
Senate Floor Amendment No. 2 Be Approved for Consideration Assignments
May 19, 2026 · Senate
Senate Floor Amendment No. 2 Referred to Assignments
May 18, 2026 · Senate
Senate Floor Amendment No. 2 Filed with Secretary by Sen. Suzy Glowiak Hilton
May 18, 2026 · Senate
Placed on Calendar Order of 3rd Reading May 18, 2026
May 14, 2026 · Senate
Second Reading
May 14, 2026 · Senate
Placed on Calendar Order of 2nd Reading May 7, 2026
May 6, 2026 · Senate
Do Pass Insurance; 009-000-000
May 6, 2026 · Senate
Senate Committee Amendment No. 1 Referred to Assignments
May 6, 2026 · Senate
Senate Committee Amendment No. 1 Filed with Secretary by Sen. Suzy Glowiak Hilton
May 6, 2026 · Senate
Assigned to Insurance
April 28, 2026 · Senate
Referred to Assignments
March 26, 2026 · Senate
First Reading
March 26, 2026 · Senate
Chief Senate Sponsor Sen. Suzy Glowiak Hilton
March 26, 2026 · Senate
Added Chief Co-Sponsor Rep. Janet Yang Rohr
March 9, 2026 · House
Added Co-Sponsor Rep. Michelle Mussman
March 2, 2026 · House
Placed on Calendar Order of First Reading March 3, 2026
February 26, 2026 · Senate
Arrive in Senate
February 26, 2026 · Senate
Third Reading - Short Debate - Passed 105-000-000
February 25, 2026 · House
Placed on Calendar Order of 3rd Reading - Short Debate
February 25, 2026 · House
Placed on Calendar 2nd Reading - Short Debate
February 13, 2026 · House
Approved for Consideration Rules Committee; 005-000-000
February 11, 2026 · House
Added Chief Co-Sponsor Rep. Martha Deuter
January 21, 2026 · House
Rule 19(a) / Re-referred to Rules Committee
April 11, 2025 · House
Added Co-Sponsor Rep. Camille Y. Lilly
April 8, 2025 · House
Held on Calendar Order of Second Reading - Short Debate
March 26, 2025 · House
Second Reading - Short Debate
March 26, 2025 · House
Added Co-Sponsor Rep. Dagmara Avelar
March 26, 2025 · House
Added Co-Sponsor Rep. Harry Benton
March 26, 2025 · House
Added Co-Sponsor Rep. Jawaharial Williams
March 26, 2025 · House
Placed on Calendar 2nd Reading - Short Debate
March 20, 2025 · House
Do Pass / Short Debate Prescription Drug Affordability & Accessibility Committee; 013-000-000
March 19, 2025 · House
Assigned to Prescription Drug Affordability & Accessibility Committee
March 11, 2025 · House
Referred to Rules Committee
February 18, 2025 · House
First Reading
February 18, 2025 · House
Filed with the Clerk by Rep. Joyce Mason
February 7, 2025 · House